Skip to main content

Table 2 Preoperative characteristics of the patients

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

Characteristic Remifentanil Dexmedetomidine
n = 47 (50.00%) n = 47 (50.00%)
Age (years) 49.57 ± 11.09 51.17 ± 10.15
Sex (male/female) 44/3 38/9
Body mass index (kg/m2) 22.73 ± 3.12 21.89 ± 2.65
Baseline AST (U/L) 37.60 ± 14.77 37.36 ± 20.12
Baseline ALT (U/L) 37.68 ± 22.20 35.55 ± 21.91
Baseline ALB (g/L) 40.20 ± 5.05 39.73 ± 4.17
Baseline TBIL (μmol/L) 20.15 ± 15.55 18.29 ± 12.56
Baseline PT (s) 14.46 ± 1.23 14.27 ± 1.59
Baseline PT% activity 85.34 ± 14.42 85.57 ± 14.49
  1. Data are expressed as mean ± standard deviation, or numbers. None of the variables significantly differed between the two groups (P > 0.05)
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, PT prothrombin time